# Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

> **NCT05866887** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 25 (actual)

## Conditions studied

- Pediatric Acute Lymphoblastic Leukemia
- Leukemia
- Acute Lymphoblastic Leukemia

## Interventions

- **BEHAVIORAL:** Sleep ALL Night

## Key facts

- **NCT ID:** NCT05866887
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-26
- **Primary completion:** 2024-06-05
- **Final completion:** 2024-06-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05866887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05866887, "Insomnia Prevention in Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05866887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*